Cancer centers in the US are facing shortages of life-saving drugs, survey finds
North AmericaHealthModerate confidence — 73/100
America’s cancer treatment centers are continuing to face a years-long cancer drug shortage with implications for patient care, a new survey of more than 30 academic facilities reveals.
All of the centers included in the survey report experiencing a shortage for at least one anti-cancer therapy and more than 20 percent of centers are currently in shortage for five or more different medications.
The drugs treat some of the top-killing cancers, including testicular, bladder, uterine, ovarian, lung and breast cancer.
Unverified
America’s cancer treatment centers are continuing to face a years-long cancer drug shortage with implications for patient care, a new survey of more than 30 academic facilities reveals.
All of the centers included in the survey report experiencing a shortage for at least one anti-cancer therapy and more than 20 percent of centers are currently in shortage for five or more different medications.
The drugs treat some of the top-killing cancers, including testicular, bladder, uterine, ovarian, lung and breast cancer.